State Street Corp Standard Biotools Inc. Transaction History

State Street Corp

  • $2.36 Trillion
  • Q1 2025

A detailed history of State Street Corp transactions in Standard Biotools Inc. stock. As of the latest transaction made, State Street Corp holds 6,359,129 shares of LAB stock, worth $8.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,359,129
Previous 6,290,000 1.1%
Holding current value
$8.58 Million
Previous $11 Million 37.61%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$1.01 - $2.06 $69,820 - $142,405
69,129 Added 1.1%
6,359,129 $6.87 Million
Q4 2024

Feb 14, 2025
BUY
$1.5 - $2.26 $1.19 Million - $1.8 Million
794,864 Added 14.46%
6,290,000 $11 Million
Q3 2024

Nov 14, 2024
BUY
$1.42 - $2.35 $1.64 Million - $2.72 Million
1,157,984 Added 26.7%
5,495,136 $10.6 Million
Q2 2024

Aug 14, 2024
BUY
$1.65 - $2.92 $4.94 Million - $8.75 Million
2,995,795 Added 223.34%
4,337,152 $7.68 Million
Q1 2024

May 15, 2024
BUY
$1.87 - $2.78 $1.95 Million - $2.9 Million
1,042,720 Added 349.16%
1,341,357 $3.64 Million
Q4 2023

Feb 14, 2024
BUY
$1.59 - $2.73 $30,369 - $52,143
19,100 Added 6.83%
298,637 $659,000
Q1 2023

May 15, 2023
SELL
$1.3 - $2.24 $2,860 - $4,928
-2,200 Reduced 0.78%
279,537 $545,000
Q3 2022

Nov 15, 2022
SELL
$1.1 - $2.06 $58,410 - $109,386
-53,100 Reduced 15.86%
281,737 $310,000
Q2 2022

Aug 15, 2022
SELL
$1.6 - $3.99 $1.93 Million - $4.8 Million
-1,203,269 Reduced 78.23%
334,837 $536,000
Q1 2022

May 16, 2022
BUY
$2.8 - $3.96 $198,926 - $281,338
71,045 Added 4.84%
1,538,106 $5.52 Million
Q4 2021

Feb 14, 2022
BUY
$3.63 - $6.13 $53,647 - $90,595
14,779 Added 1.02%
1,467,061 $5.75 Million
Q3 2021

Nov 15, 2021
BUY
$5.5 - $7.41 $31,295 - $42,162
5,690 Added 0.39%
1,452,282 $9.57 Million
Q2 2021

Aug 16, 2021
BUY
$4.35 - $6.35 $751,427 - $1.1 Million
172,742 Added 13.56%
1,446,592 $8.91 Million
Q1 2021

May 17, 2021
SELL
$3.94 - $7.09 $161,039 - $289,789
-40,873 Reduced 3.11%
1,273,850 $5.76 Million
Q4 2020

Feb 16, 2021
BUY
$5.45 - $8.65 $371,319 - $589,341
68,132 Added 5.47%
1,314,723 $7.89 Million
Q3 2020

Nov 10, 2020
SELL
$4.34 - $11.43 $245,648 - $646,949
-56,601 Reduced 4.34%
1,246,591 $9.26 Million
Q2 2020

Aug 14, 2020
SELL
$1.85 - $5.29 $154,948 - $443,069
-83,756 Reduced 6.04%
1,303,192 $5.23 Million
Q1 2020

May 11, 2020
BUY
$1.24 - $4.35 $1.72 Million - $6.03 Million
1,386,948 New
1,386,948 $3.52 Million

Others Institutions Holding LAB

# of Institutions
153
Shares Held
279M
Call Options Held
6K
Put Options Held
36.6K
View Full List

About STANDARD BIOTOOLS INC.

LAB Quotes by TradingView
  • Ticker LAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 78,654,800
  • Market Cap $106M
  • Description
  • Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...
More about LAB
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email